(1)
Mennini, F. S.; Paoletti, M.; Bini, C.; Marcellusi, A.; Falcone, M.; Andreoni, M. Cost-Utility Analysis of ceftolozane/Tazobactam Vs Meropenem in Patients With Hospital-Acquired Pneumonia (HABP) or Ventilator-Associated Pneumonia (VABP). Grhta 2022, 9, 45-57.